CLARITEV CORP (CTEV) Stock Price, Forecast & Analysis

NYSE:CTEV • US62548M2098

22.99 USD
+3.01 (+15.07%)
At close: Feb 13, 2026
23.3845 USD
+0.39 (+1.72%)
After Hours: 2/13/2026, 8:04:00 PM

CTEV Key Statistics, Chart & Performance

Key Statistics
Market Cap380.02M
Revenue(TTM)951.00M
Net Income(TTM)-341.68M
Shares16.53M
Float9.13M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-20.48
PEN/A
Fwd PEN/A
Earnings (Next)02-23
IPO2020-02-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
CTEV short term performance overview.The bars show the price performance of CTEV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

CTEV long term performance overview.The bars show the price performance of CTEV in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CTEV is 22.99 USD. In the past month the price decreased by -23.52%.

CLARITEV CORP / CTEV Daily stock chart

CTEV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CTEV Full Technical Analysis Report

CTEV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CTEV. Both the profitability and financial health of CTEV have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CTEV Full Fundamental Analysis Report

CTEV Financial Highlights

Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -20.48. The EPS increased by 67.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -6.85%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%82.56%
Sales Q2Q%6.71%
EPS 1Y (TTM)67.52%
Revenue 1Y (TTM)0.89%
CTEV financials

CTEV Forecast & Estimates

9 analysts have analysed CTEV and the average price target is 66.1 USD. This implies a price increase of 187.5% is expected in the next year compared to the current price of 22.99.

For the next year, analysts expect an EPS growth of 76.25% and a revenue growth 2.9% for CTEV


Analysts
Analysts84.44
Price Target66.1 (187.52%)
EPS Next Y76.25%
Revenue Next Year2.9%
CTEV Analyst EstimatesCTEV Analyst Ratings

CTEV Ownership

Ownership
Inst Owners48.15%
Ins Owners6.93%
Short Float %9.9%
Short Ratio4.32
CTEV Ownership

CTEV Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
VEEV VEEVA SYSTEMS INC-CLASS A19.8828.272B
DOCS DOXIMITY INC-CLASS A14.294.564B
WAY WAYSTAR HOLDING CORP13.574.159B
HTFL HEARTFLOW INC N/A1.915B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP231.731.099B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A1.078B
CERT CERTARA INC11.921.062B
SDGR SCHRODINGER INC N/A833.095M
TDOC TELADOC HEALTH INC N/A792.754M
GDRX GOODRX HOLDINGS INC-CLASS A4.94739.957M

About CTEV

Company Profile

CTEV logo image Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

Company Info

CLARITEV CORP

7900 Tysons One Place, Suite 400

McLean VIRGINIA US

Employees: 2700

CTEV Company Website

CTEV Investor Relations

Phone: 12127802000

CLARITEV CORP / CTEV FAQ

Can you describe the business of CLARITEV CORP?

Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.


What is the stock price of CLARITEV CORP today?

The current stock price of CTEV is 22.99 USD. The price increased by 15.07% in the last trading session.


Does CTEV stock pay dividends?

CTEV does not pay a dividend.


What is the ChartMill rating of CLARITEV CORP stock?

CTEV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the PE ratio for CTEV stock?

CLARITEV CORP (CTEV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.48).


Can you provide the market cap for CLARITEV CORP?

CLARITEV CORP (CTEV) has a market capitalization of 380.02M USD. This makes CTEV a Small Cap stock.


Can you provide the short interest for CTEV stock?

The outstanding short interest for CLARITEV CORP (CTEV) is 9.9% of its float.